Cardiac
NUR 211 Cardiac/Perfusion Exam ReviewMain concept: perfusion
Perfusion is the delivery of oxygenated blood to the tissues.
Signs of decreased perfusion can include:
Chest pain
Altered mental status
Hypotension
Tachycardia
Cool, pale or clammy skin
Weak peripheral pulses
Delayed capillary refill
Decreased urine output
Fatigue or activity intolerance
Dizziness or syncope
Cardiac output equals:
Cardiac output = heart rate × stroke volume
When cardiac output falls, the brain, kidneys, skin and other organs receive less blood.
Important assessment areas:
Vital signs
Oxygen saturation
Level of consciousness
Skin color, temperature and moisture
Peripheral pulses and capillary refill
Urine output
Edema and JVD
Lung sounds
Heart sounds
Chest-pain assessment
ECG or telemetry findings
Important heart sounds:
S3: commonly associated with volume overload and heart failure
S4: associated with a stiff or noncompliant ventricle
Murmur: turbulent blood flow, often from valve disease
Pericardial friction rub: inflammation of the pericardium
Chapter 24: Coronary Vascular DisordersAtherosclerosis versus arteriosclerosisAtherosclerosis
Abnormal accumulation of lipids and fibrous tissue inside an arterial wall and lumen.
The plaque narrows the coronary artery and reduces blood flow to the myocardium.
If a plaque ruptures:
The plaque contents are exposed.
Platelets become activated.
A thrombus forms.
Coronary blood flow decreases or stops.
The patient can develop unstable angina, NSTEMI or STEMI.
Arteriosclerosis
Thickening and loss of elasticity of the arteries.
Atherosclerosis is a particular type of arteriosclerosis involving plaque formation.
CAD risk factorsModifiable risk factors
Smoking or tobacco use
Hypertension
Hyperlipidemia
Diabetes
Obesity
Sedentary lifestyle
Poor diet
Uncontrolled stress
Nonmodifiable risk factors
Age
Family history
Genetics
Sex-related risk patterns
Metabolic syndrome
Metabolic syndrome is a cluster of conditions that increases cardiovascular risk:
Hypertension
Hyperglycemia
Excess abdominal fat
Abnormal cholesterol or triglycerides
Angina Pectoris
Angina occurs when myocardial oxygen demand exceeds the available oxygen supply.
Typical descriptions include:
Pressure
Tightness
Heaviness
Choking
Squeezing
The discomfort is frequently retrosternal and may radiate to:
Neck
Jaw
Shoulders
Back
One or both arms, usually the left
Epigastric region
Associated symptoms can include:
Dyspnea
Diaphoresis
Dizziness
Nausea or vomiting
Anxiety
Weakness
Fatigue
Older adults, women and patients with diabetes may have atypical manifestations:
Unexplained dyspnea
Fatigue
Weakness
Indigestion
Nausea
Confusion
Little or no chest pain
Stable angina
Stable angina is:
Predictable
Usually caused by exertion or emotional stress
Relieved by rest or nitroglycerin
Not associated with myocardial necrosis
Associated with a normal troponin
Teaching includes:
Stop activity when discomfort begins.
Sit down and rest.
Use nitroglycerin as prescribed.
Keep nitroglycerin available.
Follow the prescribed emergency plan if pain is not relieved.
Unstable angina
Unstable angina is:
New chest pain
Increasingly frequent chest pain
More severe or prolonged pain
Pain occurring at rest
Pain less responsive to rest or nitroglycerin
Considered acute coronary syndrome
There is ischemia but no measurable myocardial necrosis.
Expected findings:
Troponin remains normal
ECG may be normal
ECG may show ST depression
ECG may show T-wave inversion
Acute Coronary Syndrome
ACS includes:
Unstable angina
NSTEMI
STEMI
Unstable angina versus NSTEMI versus STEMIUnstable angina
Coronary ischemia without myocardial necrosis
Troponin remains normal
ECG may show ST depression or T-wave inversion
Symptoms may be new, worsening or occurring at rest
NSTEMI
Usually caused by partial or severe coronary obstruction
Myocardial necrosis occurs
Troponin is elevated
ECG commonly shows ST depression or T-wave inversion
Does not produce the diagnostic ST elevation of a STEMI
STEMI
Usually caused by complete coronary occlusion
Myocardial necrosis occurs
Troponin is elevated
ECG shows ST-segment elevation
Kim’s slide specifies:
At least 1 mm of ST elevation in two anatomically contiguous leads supports STEMI.
High-yield comparison
Disorder | Troponin | Common ECG finding | Necrosis |
|---|---|---|---|
Stable angina | Normal | May be normal between episodes | No |
Unstable angina | Normal | ST depression or T-wave inversion may occur | No |
NSTEMI | Elevated | ST depression or T-wave inversion | Yes |
STEMI | Elevated | ST elevation in contiguous leads | Yes |
The major difference between unstable angina and NSTEMI is the troponin:
NSTEMI = elevated troponin
Unstable angina = normal troponin
Cardiac Diagnostics and NumbersTwelve-lead ECG
The ECG should be obtained rapidly for suspected ACS.
It is used to identify:
Ischemia
Injury
ST elevation
ST depression
T-wave inversion
Dysrhythmias
Area of the myocardium affected
A normal or nondiagnostic initial ECG does not automatically rule out ACS.
Troponin
Troponin is the primary laboratory marker of myocardial injury.
Know Kim’s numbers:
Begins to rise approximately 2–3 hours after chest-pain onset
Generally peaks between 12–48 hours
Falls toward normal over approximately 4–10 days
An early normal troponin may require repeat or serial testing.
CK-MB
CK-MB is another cardiac isoenzyme associated with myocardial injury.
Troponin is the more important marker in the provided material, but CK-MB may help evaluate possible reinfarction because it returns to baseline sooner.
BNP
BNP is secreted by the ventricles in response to excessive ventricular stretching.
Kim’s NSTEMI handout states:
BNP greater than 100 may indicate heart failure.
Always interpret BNP with the patient’s assessment and the facility’s reference range.
Other labs
CBC
Chemistry panel
BUN and creatinine
Potassium
Magnesium
Glucose
Lipid panel
PT/INR
aPTT
Hemoglobin and hematocrit
These help identify:
Anemia
Electrolyte disturbances
Kidney dysfunction
Bleeding risk
Diabetes
Lipid abnormalities
Echocardiogram
Evaluates:
Heart chambers
Valve structure
Valve function
Wall motion
Ejection performance
Pericardial effusion
Stress testing
Used to identify inducible ischemia in an appropriate, stable patient.
Stress testing is not the first action for a patient experiencing active, unstable ACS symptoms.
Initial Nursing Care for Chest Pain
For new chest pain:
Stop the patient’s activity.
Position the patient at rest.
Perform a rapid ABC assessment.
Obtain vital signs and oxygen saturation.
Complete a focused chest-pain assessment.
Obtain or prepare for a 12-lead ECG.
Establish IV access.
Draw ordered laboratory tests.
Administer ordered or protocol-directed medications.
Continually reassess pain, vital signs and ECG findings.
Prepare for reperfusion or a higher level of care when indicated.
Kim’s PowerPoint specifically says:
Place the patient in semi-Fowler’s position
Administer oxygen at 2 L/min by nasal cannula
Give nitroglycerin and reassess
Nitroglycerin may be given for up to three doses
For clinical safety, oxygen is generally guided by:
Oxygen saturation
Respiratory distress
Hypoxemia
Provider orders
Facility protocol
Know Kim’s specific slide directions for the exam.
Important Cardiac MedicationsAspirin
Used early in suspected ACS because it inhibits platelet aggregation.
Nursing considerations:
Check for allergy
Check for active bleeding
Usually given in chewable form during ACS
Monitor for GI or other bleeding
Nitroglycerin
Nitroglycerin causes vasodilation and reduces myocardial workload and oxygen demand.
Before giving it:
Check blood pressure.
Assess the chest pain.
Ask about recent PDE-5 inhibitor use.
Check the medication order or protocol.
Examples of PDE-5 inhibitors include sildenafil and tadalafil.
Combining these drugs with nitroglycerin can cause profound hypotension.
Adverse effects:
Hypotension
Headache
Dizziness
Flushing
Expected therapeutic response:
Reduced chest discomfort
Metoprolol and other beta blockers
Beta blockers:
Decrease heart rate
Decrease blood pressure
Decrease myocardial workload
Decrease myocardial oxygen demand
Before administration:
Check heart rate
Check blood pressure
Evaluate for symptomatic bradycardia or hypotension
Evaluate for worsening decompensated heart failure
ACE inhibitors and ARBs
These reduce afterload and may help manage:
Hypertension
Heart failure
Ventricular remodeling following MI
Monitor:
Blood pressure
Potassium
BUN and creatinine
Renal function
ACE-inhibitor complications:
Dry cough
Hyperkalemia
Hypotension
Angioedema
Facial, tongue or throat swelling is an emergency.
Diuretics
Decrease excess fluid and pulmonary/systemic congestion.
Monitor:
Daily weight
Intake and output
Blood pressure
Lung sounds
Edema
Potassium
Sodium
Renal function
Antiplatelet medications
Aspirin and P2Y12 inhibitors help prevent platelet aggregation.
Patients with coronary stents may receive dual antiplatelet therapy.
Important teaching:
Do not stop antiplatelet medication without speaking to the cardiology team.
Monitor for bleeding.
Report black stools, bloody urine, unusual bruising or persistent bleeding.
Anticoagulants
Anticoagulants prevent clot formation or propagation but do not directly dissolve an existing clot.
Nursing considerations:
Monitor for bleeding.
Check the ordered coagulation studies.
Use bleeding precautions.
Review kidney function when relevant.
Verify correct dose and indication.
Thrombolytics
Thrombolytics dissolve a thrombus but do not correct the underlying atherosclerotic plaque.
They may be used for an eligible STEMI patient when timely PCI is unavailable.
They are not routinely used for:
NSTEMI
Unstable angina
Major contraindications include:
Active internal bleeding
Known bleeding disorder
Previous intracranial hemorrhage
Recent major surgery or trauma, depending on timing
Certain severe or uncontrolled hypertension presentations
Kim’s handout emphasizes:
Door-to-needle goal: approximately 30 minutes when thrombolytic therapy is indicated.
PCI, PTCA and Coronary StentsPCI/PTCA
A balloon-tipped catheter is used to open a narrowed or blocked coronary artery.
A stent may be placed to keep the vessel open.
Possible complications:
Coronary artery dissection
Coronary perforation
Abrupt vessel closure
Acute MI
Reperfusion dysrhythmias
Ventricular tachycardia
Cardiac arrest
Bleeding
Hematoma
Retroperitoneal bleeding
Embolic complications
Acute kidney injury from contrast
Post-cardiac catheterization/PCI care
Assess:
Vital signs
Cardiac rhythm
Chest pain
Insertion site
Bleeding or hematoma
Peripheral pulses
Color and temperature of the affected extremity
Capillary refill
Movement and sensation
BUN and creatinine
Urine output
Kim’s slide specifies:
Remain flat for a minimum of four hours after femoral sheath removal.
Positioning and activity restrictions may depend on the access site, closure device and facility protocol.
Retroperitoneal bleeding
Watch for:
Back or flank pain
Hypotension
Tachycardia
Falling hemoglobin or hematocrit
Restlessness
Weakness
Signs of hypovolemia
Do not massage an enlarging hematoma.
CABG
CABG means coronary artery bypass graft.
A blood vessel is grafted around an occluded coronary artery so blood can flow beyond the obstruction.
Possible indications:
Chest pain not controlled with medication
CAD not adequately treated with PCI
Significant coronary anatomy that is better treated surgically
Prevention or treatment of complications related to ischemia
Post-CABG nursing assessment
Monitor:
Neurologic status
Cardiac output and perfusion
Heart rate and rhythm
Blood pressure
Respiratory status
Oxygenation
Chest-tube drainage
Bleeding
Peripheral circulation
Urine output
BUN and creatinine
Fluid and electrolytes
Blood glucose
Temperature
Pain
Goals include:
Adequate cardiac output
Adequate tissue perfusion
Adequate gas exchange
Fluid and electrolyte balance
Glycemic control
Adequate kidney perfusion
Pain relief
Prevention of delirium and complications
Complications of ACS and MIDysrhythmias and cardiac arrest
Dysrhythmias are major early complications of MI.
Kim’s slide states:
More than 50% of deaths from MI occur within the first 72 hours.
The patient requires continuous rhythm monitoring.
Cardiogenic shock
Cardiogenic shock occurs when the heart cannot pump enough blood to support the organs.
Findings:
Hypotension
Tachycardia
Weak pulses
Cool, pale or clammy skin
Altered mental status
Decreased urine output
Pulmonary congestion
Increasing dyspnea
Heart failure
Findings can include:
Dyspnea
Orthopnea
Crackles
Hypoxemia
S3
Edema
JVD
Rapid weight gain
Decreased urine output
Reduced activity tolerance
Cardiac tamponade
Fluid or blood accumulates in the pericardial sac and compresses the heart.
This prevents adequate ventricular filling and reduces cardiac output.
Findings:
Hypotension
Tachycardia
JVD
Muffled heart sounds
Narrow pulse pressure
Weak pulses
Restlessness
Decreased urine output
Poor perfusion
Beck’s triad
Hypotension
JVD
Muffled heart sounds
Cardiac tamponade is an emergency.
Chapter 25: Structural, Infectious and Inflammatory DisordersInfective Endocarditis
Infective endocarditis is infection and inflammation of the endocardial surface, usually involving the heart valves.
Risk factors:
Prosthetic heart valve
Previous endocarditis
Congenital or structural heart disease
Rheumatic heart disease
IV drug use
Invasive procedures
Poor oral hygiene
Bacteremia
Indwelling vascular catheters
Prolonged IV therapy
Immunocompromised state
Assessment findings:
Fever
Chills
Malaise
Fatigue
Weight loss
New or changing murmur
Petechiae
Heart-failure manifestations
Stroke or other embolic manifestations
Important peripheral findings:
Osler nodes: painful nodules on the fingers or toes
Janeway lesions: painless red or purple macules on the palms or soles
Splinter hemorrhages: small hemorrhages under the nails
Roth spots: retinal hemorrhages
Memory aid:
Osler = ouch = painful
Diagnostics:
Blood cultures
CBC
Echocardiogram
ECG
Other tests based on complications
When possible, obtain ordered blood cultures before beginning antimicrobial therapy.
Treatment:
Prolonged organism-specific antimicrobial therapy
Management of heart failure
Management of embolic complications
Valve repair or replacement if severe damage occurs
Complications:
Heart failure
Valve destruction
Embolic stroke
Systemic emboli
Abscess formation
Sepsis
Rheumatic Fever and Rheumatic Heart Disease
Rheumatic fever is an autoimmune inflammatory reaction that can occur following group A beta-hemolytic streptococcal pharyngitis.
Symptoms commonly begin:
Approximately 1–6 weeks after strep throat
Important manifestations:
Fever
Migratory polyarthritis
Carditis or new murmur
Chorea
Erythema marginatum
Subcutaneous nodules
Prevention:
Promptly diagnose strep throat.
Complete the prescribed antibiotic treatment.
Reinforce long-term preventive therapy when ordered.
Chronic rheumatic heart disease commonly damages the mitral valve and can cause:
Mitral stenosis
Mitral regurgitation
Myocarditis
Myocarditis is inflammation of the myocardium.
It is often caused by a viral infection but may result from other infectious, autoimmune or toxic causes.
It can damage:
Cardiac muscle fibers
Myocardial contractility
Electrical conduction system
Manifestations:
Fatigue
Dyspnea
Chest discomfort
Palpitations
Dysrhythmias
Signs of acute heart failure
A major clue is an otherwise healthy patient who rapidly develops:
Acute decompensated heart failure
Dysrhythmias
Decreased cardiac output
Management is primarily supportive and directed at:
Treating the cause
Reducing cardiac workload
Managing heart failure
Managing dysrhythmias
Preventing complications
Pericarditis
Pericarditis is inflammation of the pericardial sac.
Possible causes:
Viral infection
MI
Cardiac surgery
Autoimmune disease
Certain medications
Other infections or inflammatory processes
Assessment findings:
Sharp, stabbing or pleuritic chest pain
Pain worsens with deep inspiration
Pain worsens when lying flat
Pain improves when sitting up and leaning forward
Fever
Pericardial friction rub
Dyspnea
This helps differentiate pericarditis from myocardial ischemia:
Pericarditis: sharp, pleuritic and positional
MI/angina: pressure, heaviness or squeezing; generally not relieved by leaning forward
Treatment depends on the cause and may include:
NSAIDs or other anti-inflammatory therapy
Colchicine, depending on the prescribed regimen
Corticosteroids in selected cases
Antibiotics when caused by bacterial infection
Complications:
Pericardial effusion
Cardiac tamponade
Constrictive pericarditis
Pericardiocentesis
Pericardiocentesis removes fluid from the pericardial space.
Reasons:
Relieve cardiac tamponade
Improve cardiac output
Obtain fluid for diagnostic testing
Before and during:
Explain the procedure.
Obtain baseline vital signs.
Establish IV access.
Maintain ECG monitoring.
Monitor blood pressure and respiratory status.
Position as ordered, commonly semi-Fowler’s.
Prepare sterile equipment.
Afterward, monitor for:
Improved blood pressure
Decreased JVD
Improved heart sounds
Improved perfusion
Improved dyspnea
Dysrhythmias
Bleeding
Pneumothorax
Infection
Reaccumulation of fluid
Valve DisordersBasic definitionsStenosis
The valve does not open completely.
This obstructs forward blood flow and increases the workload of the chamber pumping through the valve.
Think:
Stenosis = tight = will not open
Regurgitation
The valve does not close completely.
Blood leaks backward through the valve.
Think:
Regurgitation = floppy or leaky = will not close
Prolapse
A valve leaflet bulges backward into the chamber behind it.
Mitral Valve Prolapse
The mitral leaflets bulge into the left atrium during systole.
Often asymptomatic.
Possible findings:
Palpitations
Dizziness
Fatigue
Anxiety
Chest discomfort
Dyspnea
Midsystolic click
Murmur
Management:
Symptom management
Follow-up examinations
Monitoring for progression to mitral regurgitation
Education about symptoms of endocarditis
Mitral Regurgitation
The mitral valve does not close completely.
Blood flows:
Left ventricle → back into left atrium during systole
Result:
Increased left-atrial volume
Pulmonary congestion
Increased left-ventricular workload
Decreased forward cardiac output
Possible heart failure
Findings:
Cough
Dyspnea
Orthopnea
Fatigue
Palpitations
Murmur
Crackles
S3
Heart-failure manifestations
Possible causes:
Mitral valve prolapse
Rheumatic heart disease
Infective endocarditis
Ischemic heart disease
Left-ventricular enlargement
Papillary-muscle dysfunction following MI
Mitral Stenosis
The mitral valve is narrowed.
Blood flow is obstructed:
Left atrium → left ventricle
Result:
Increased pressure in the left atrium
Blood backs into pulmonary circulation
Pulmonary congestion develops
Pulmonary hypertension may develop
Right-sided heart failure may eventually occur
Findings:
Dyspnea on exertion
Orthopnea
Fatigue
Dizziness
Palpitations
Chest discomfort
Cough
Hemoptysis
Murmur
Atrial fibrillation
Heart-failure manifestations
Important complication:
Left-atrial enlargement can cause atrial fibrillation and blood stasis, increasing the risk of:
Atrial thrombus
Embolic stroke
Rheumatic heart disease is an important cause of mitral stenosis.
Aortic Regurgitation
The aortic valve does not close completely.
Blood flows:
Aorta → back into left ventricle during diastole
Result:
Left-ventricular volume overload
Left-ventricular enlargement
Decreased forward cardiac output
Eventually heart failure
Findings:
Forceful heartbeat in the head or neck
Bounding peripheral pulses
Wide pulse pressure
Dyspnea
Fatigue
Palpitations
Chest pain
Diastolic murmur
Heart-failure manifestations
Possible causes:
Congenital bicuspid valve
Rheumatic endocarditis
Infective endocarditis
Aortic dilation
Aortic dissection
Degenerative valve changes
Aortic Stenosis
The aortic valve does not open completely.
Blood flow is obstructed:
Left ventricle → aorta
Result:
Left ventricle must generate greater pressure.
Left-ventricular hypertrophy develops.
Cardiac output decreases.
Myocardial oxygen demand increases.
Heart failure may eventually occur.
Classic symptoms:
SAD
S: Syncope
A: Angina
D: Dyspnea
Other findings:
Fatigue
Palpitations
S4
Systolic murmur
Reduced activity tolerance
Heart-failure manifestations
Severe aortic stenosis can cause sudden cardiac death.
Valve Management
Medical management can include:
Diuretics
ACE inhibitors
ARBs
Beta blockers
Dysrhythmia management
Anticoagulation when indicated
Heart-failure management
The patient may eventually require:
Balloon valvuloplasty
Commissurotomy
Annuloplasty
Valve repair
Valve replacement
Transcatheter aortic valve replacement
Balloon valvuloplasty
A catheter with a balloon is used to open a stenotic valve.
It is performed in the catheterization lab.
Monitor for:
Bleeding
Hematoma
Dysrhythmias
Embolic event
Heart failure
Valve damage
Regurgitation
Restenosis
Postprocedure care is similar to post-cardiac catheterization care.
Chapter 25 notes:
The balloon may be inflated for approximately 15–60 seconds
Aortic balloon valvuloplasty can have a restenosis rate of approximately 50% within the first six months
These textbook numbers may be lower-priority than the PowerPoint information, but they are worth recognizing.
Commissurotomy/valvotomy
Surgical separation or incision of fused valve leaflets to relieve stenosis.
Annuloplasty
A ring or band is placed around the valve annulus to reshape and support it.
Mechanical Versus Tissue ValvesMechanical valve
Advantages:
Very durable
Long-lasting
Disadvantages:
Higher clot risk
Usually requires lifelong anticoagulation with warfarin
Tissue or bioprosthetic valve
Advantages:
Lower clot risk
Often does not require lifelong anticoagulation unless another indication exists
Disadvantages:
Less durable
Kim’s PowerPoint states:
Bioprosthetic valves may last approximately 7–10 years.
Types mentioned in the chapter/slides:
Cow tissue
Pig tissue
Horse tissue
Homograft from human donor tissue
Autograft using the patient’s own pulmonic valve
Warfarin Teaching
The patient should:
Take warfarin exactly as prescribed.
Obtain PT/INR testing.
Keep vitamin K intake consistent.
Avoid suddenly increasing or decreasing vitamin K-rich foods.
Use bleeding precautions.
Report unusual bruising.
Report bleeding gums.
Report nosebleeds.
Report blood in urine or stool.
Report black, tarry stools.
Consult the provider before taking NSAIDs, OTC medications or herbal products.
Never stop warfarin independently.
Wear medical-alert identification.
Cardiomyopathies
Cardiomyopathy is disease of the heart muscle associated with cardiac dysfunction.
Dilated cardiomyopathy
The ventricles enlarge and contract poorly.
This causes systolic dysfunction and reduced cardiac output.
Findings:
Dyspnea
Orthopnea
Fatigue
Crackles
Edema
S3
Dysrhythmias
Heart failure
Possible thromboembolism from blood stasis
Hypertrophic cardiomyopathy
The myocardium becomes abnormally thick, often involving the septum.
This can:
Reduce ventricular filling
Obstruct left-ventricular outflow
Reduce cardiac output
Cause dangerous dysrhythmias
Findings:
Exertional dyspnea
Angina
Syncope
Palpitations
Sudden cardiac death
Major dehydration or sudden preload reduction can worsen outflow obstruction in susceptible patients.
Restrictive cardiomyopathy
The ventricles become stiff and cannot fill normally.
This produces diastolic dysfunction.
Findings:
Fatigue
Exercise intolerance
JVD
Edema
Pulmonary or systemic congestion
Signs of reduced cardiac output
Cardiomyopathy nursing priorities
Monitor cardiac rhythm.
Assess perfusion.
Monitor respiratory status.
Assess for heart failure.
Monitor daily weight.
Measure intake and output.
Monitor renal function.
Administer prescribed medications.
Teach individualized activity restrictions.
Teach the patient to report syncope, chest pain, palpitations or worsening dyspnea.
The cardiomyopathy information is in Chapter 25 but is not emphasized as heavily in Kim’s HYBRID PowerPoint as valves, endocarditis, myocarditis and pericarditis.
“Old Bones” Fundamentals Kim Could AddPrioritization
ABCs come before routine teaching or documentation.
Acute problems come before chronic problems.
Unexpected findings come before expected findings.
Unstable patients come before stable patients.
Actual problems generally come before potential problems.
New chest pain, hypotension, altered LOC, active bleeding or a new neurologic deficit requires rapid attention.
Medication administration
Before giving a medication:
Verify allergies.
Confirm indication.
Check relevant vital signs.
Check relevant laboratory results.
Check contraindications.
Confirm the correct patient, medication, dose, route and time.
Evaluate whether the patient can safely receive it.
After giving a medication:
Reassess the intended effect.
Monitor for adverse effects.
Document the response.
Consent
The procedural provider obtains informed consent.
The nurse:
Verifies that consent is signed
Witnesses according to policy
Confirms the patient is voluntarily consenting
Reports unanswered questions to the provider
The nurse should not provide the procedural explanation in place of the provider.
Delegation
The RN does not delegate:
Initial assessment
Clinical judgment
Patient teaching
Evaluation
Care of an unstable patient
Experienced unlicensed personnel may obtain routine vital signs on a stable patient and report abnormalities.
Patient education
Use teach-back for:
Nitroglycerin
Antiplatelet medications
Warfarin
Post-cath restrictions
Surgical incision care
Symptoms requiring emergency assistance
Numbers and Facts to Know
Troponin starts rising approximately 2–3 hours after chest-pain onset.
Troponin generally peaks in 12–48 hours.
Troponin may fall toward normal over 4–10 days.
STEMI: at least 1 mm of ST elevation in two contiguous leads according to Kim’s slide.
Kim’s chest-pain slide lists oxygen at 2 L/min by nasal cannula.
Kim’s slide allows nitroglycerin for up to three doses, with reassessment.
Kim’s post-femoral-sheath slide states the patient remains flat for at least four hours.
When thrombolytics are used, the handout emphasizes a 30-minute door-to-needle goal.
Kim’s handout associates BNP greater than 100 with heart failure.
Kim’s slide states more than 50% of MI deaths occur within 72 hours.
Rheumatic fever manifestations may begin 1–6 weeks after strep throat.
Kim’s slide states tissue valves may last approximately 7–10 years.
Chapter 25 states valvuloplasty balloons may be inflated for 15–60 seconds.
Chapter 25 notes approximately 50% restenosis within six months after aortic balloon valvuloplasty.
Final High-Yield Connections
Unstable angina: ischemia, normal troponin, no necrosis
NSTEMI: elevated troponin, necrosis, ST depression/T-wave inversion
STEMI: elevated troponin, necrosis, ST elevation
Endocarditis: fever, new murmur, cultures, antibiotics, embolic risk
Myocarditis: inflamed heart muscle, rapid HF and dysrhythmias
Pericarditis: sharp positional pain, friction rub, tamponade risk
Tamponade: hypotension, JVD and muffled heart sounds
Mitral stenosis: pulmonary backup, A-fib and embolic risk
Mitral regurgitation: blood leaks from LV to LA during systole
Aortic stenosis: SAD—syncope, angina and dyspnea
Aortic regurgitation: bounding pulses and wide pulse pressure
Mechanical valve: durable but generally requires lifelong anticoagulation
Post-PCI: bleeding and distal neurovascular assessment
Cardiogenic shock: hypotension plus evidence of organ hypoperfusion